In this study, we explore the molecular landscape of HB by analyzing distinct tumor cell clusters with a particular focus on one characterized by EZH2 overexpression termed “cycling HepT.” We also evaluated HB response to EZH2 inhibition in both in vitro and in vivo models. This evidence concerns the gene EZH2 and hemoglobin measurement.